DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/mm75z5/acromegaly) has announced the addition of the "Acromegaly Pipeline Highlights - 2014 Update" report to their offering.
The latest report Acromegaly Pipeline Highlights - 2014 Update, provides most up-to-date information on key pipeline molecules in the global Acromegaly market. It covers emerging therapies for Acromegaly in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Acromegaly pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Acromegaly pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.
The report provides Acromegaly pipeline molecules by the Originator Company.
Short-term Launch Highlights:
Find out which Acromegaly pipeline products will be launched in the US and Ex-US till 2017.
Key Topics Covered:
1. Acromegaly Pipeline by Stages
2. Acromegaly Pipeline by Drug Class
3. Acromegaly Pipeline by Company
4. Acromegaly Phase 3 Clinical Trial Insights
5. Acromegaly Phase 2 Clinical Trial Insights
6. Acromegaly Phase 1 Clinical Trial Insights
7. Acromegaly Preclinical Research Insights
8. Acromegaly Discovery Stage Insights
10. Research Methodology
For more information visit http://www.researchandmarkets.com/research/mm75z5/acromegaly